- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Private-Payer ACOs Good for Medicare, Study Says
Medicare may enjoy the fruits of the growing and varied work among private payers and providers to boost value in healthcare, though the benefits will come sooner to costs than quality, a study suggests.
Medicare may enjoy the fruits of the growing and varied work among private payers and providers to boost value in healthcare, though the benefits will come sooner to costs than quality, a study suggests.
Harvard University researchers analyzed spending and quality measures for Medicare patients at 11 Massachusetts health systems with Blue and Cross Blue Shield contracts to manage costs and healthcare quality for commercially insured patients. Under these “alternative quality contracts,” which began in 2009 or 2010, spending fell by 1.9% during the first year and 3.3% during the second year for the commercially insured patients and quality improved.
Read the full story here: http://bit.ly/1538iqO
Source: Modern Healthcare
The research, published in the Journal of the American Medical Association, examined the extent to which strategies that lower spending and improve quality for one group of patients would spill over and indirectly benefit other patients. The results show that spending dropped among patients who were not targeted by cost-control strategies, but few quality gains.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
